Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found that hair follicle stem cells can become squamous cell carcinoma due to Ras activation, which could lead to new treatments.

Cancer development is like natural selection, involving mutated cells and environmental factors.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

Modified β-catenin can cause different effects in mouse skin cells, leading to cysts or tumors depending on the cell type.

HPV8 E6 gene causes growth of certain skin stem cells.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

Increased ODC activity leads to skin tumors by recruiting stem cells, not by toxic byproducts.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

Homozygous K5Cre transgenic mice have wavy hair and faster cancer progression.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Blocking mTORC1 may help prevent skin cancer by stopping the growth of certain skin stem cells.

Blocking mTORC1 reduces skin tumor growth in mice.

AP-1 controls tumor cell type by affecting key signaling pathways.

ETS2 drives cancer progression in squamous cell carcinoma and is linked to poor patient outcomes.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

Twist1 is crucial for UVB-induced skin cancer development.

Melanocyte pathology requires keratinocyte hyperplasia and regulation dysfunction.

Boosting certain cell signals can prevent hair loss from cancer treatments.

The type of tumor suppressor affects the form of skin cancer from hair follicle stem cells.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Overexpressing COX-2 in mice skin reduces skin tumor development.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

Cancer prevention has advanced significantly, with some strategies proving successful.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

MPA increases cancer spread by boosting Eph A2 activity.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

Activating certain hair follicle cells could prevent hair loss from cancer treatments.